智通财经APP讯，方舟健客(06086)发布公告，公司股份已获选定纳入恒生香港上市生物科技指数(“恒生香港上市生物科技指数”)，自2024年12月9日起生效。恒生香港上市生物科技指数旨在反映于香港上市的生物科技公司的整体表现。
董事会认为，股份纳入恒生香港上市生物科技指数成份股可提升公司于更为广泛的投资者中的形象，且亦可为我们的客户、合作伙伴及投资者创造机会以参与公司的创新互联网保健解决方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.